— Know what they know.
Not Investment Advice
Also trades as: GIS.DE (XETRA) · $vol 0M · GILD.SW (SIX)

GILD NASDAQ

Gilead Sciences, Inc.
1W: -1.2% 1M: -1.8% 3M: -13.8% YTD: +7.3% 1Y: +22.1% 3Y: +83.5% 5Y: +128.2%
$134.36
+3.86 (+2.96%)
 
Weekly Expected Move ±3.3%
$121 $125 $130 $134 $138
NASDAQ · Healthcare · Drug Manufacturers - General · Alpha Radar Neutral · Power 56 · $166.8B mcap · 1.24B float · 0.495% daily turnover · Short 36% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
60.9 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 26.7%  ·  5Y Avg: 13.7%
Cost Advantage
67
Intangibles
65
Switching Cost
54
Network Effect
40
Scale ★
78
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. GILD has a Narrow competitive edge (60.9/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 26.7% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$157
Low
$163
Avg Target
$168
High
Based on 3 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 39Hold: 18Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$166.67
Analysts6
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-20 Maxim Group Michael Okunewitch $84 $165 +81 +26.4% $130.55
2026-05-10 Morgan Stanley $175 $168 -7 +27.9% $131.33
2026-05-08 Truist Financial $155 $157 +2 +18.9% $132.03
2026-04-10 Morgan Stanley $171 $175 +4 +24.7% $140.34
2026-04-08 Truist Financial Gregory Renza $162 $155 -7 +9.5% $141.54
2026-03-10 Jefferies Akash Tewari $95 $180 +85 +22.5% $146.94
2026-02-19 Barclays $76 $155 +79 +2.6% $151.12
2026-02-19 Mizuho Securities $140 $170 +30 +11.3% $152.74
2026-02-18 UBS $155 $175 +20 +12.7% $155.27
2026-02-11 Scotiabank Louise Chen Initiated $177 +14.0% $155.29
2026-02-11 Bernstein Courtney Breen $135 $160 +25 +2.9% $155.45
2026-02-11 Morgan Stanley $150 $171 +21 +9.8% $155.72
2026-02-11 Truist Financial $152 $162 +10 +3.9% $155.87
2026-02-11 Truist Financial $145 $152 +7 -1.7% $154.69
2026-02-11 Oppenheimer $132 $165 +33 +7.5% $153.46
2026-02-11 Cantor Fitzgerald $135 $155 +20 +5.3% $147.23
2026-02-11 Needham Joseph Stringer Initiated $170 +10.3% $154.09
2026-02-11 Robert W. Baird $108 $145 +37 -5.8% $153.89
2026-02-11 BMO Capital Evan Seigerman $150 $160 +10 +8.7% $147.23
2026-02-11 Wells Fargo Mohit Bansal $145 $165 +20 +12.1% $147.23
2026-01-27 Truist Financial $140 $145 +5 +4.1% $139.23
2026-01-26 BMO Capital Evan David Seigerman $135 $150 +15 +9.5% $137.01
2026-01-26 UBS $145 $155 +10 +13.8% $136.16
2026-01-13 Morgan Stanley $151 $150 -1 +22.7% $122.25
2026-01-07 UBS Michael Yee $54 $145 +91 +19.5% $121.36
2025-12-29 Bernstein Courtney Breen Initiated $135 +8.4% $124.56
2025-12-15 Wolfe Research Alexandria Hammond Initiated $150 +24.6% $120.41
2025-12-12 Morgan Stanley $147 $151 +4 +22.6% $123.21
2025-12-10 HSBC $69 $133 +64 +11.4% $119.36
2025-11-25 BMO Capital Evan David Seigerman $94 $135 +41 +5.8% $127.57
2025-11-24 Truist Financial Gregory Renza $83 $140 +57 +9.5% $127.91
2025-11-20 Mizuho Securities $90 $140 +50 +12.0% $124.99
2025-10-31 Morgan Stanley Terence Flynn $143 $147 +4 +24.0% $118.52
2025-10-31 RBC Capital $83 $105 +22 -11.3% $118.44
2025-10-31 Wells Fargo $140 $145 +5 +22.4% $118.44
2025-10-09 Cantor Fitzgerald Carter Gould $125 $135 +10 +14.2% $118.25
2025-10-06 Wells Fargo $90 $140 +50 +24.2% $112.69
2025-08-11 Deutsche Bank James Shin Initiated $135 +13.6% $118.83
2025-08-08 Robert W. Baird Brian Skorney $80 $108 +28 -9.6% $119.41
2025-08-08 Morgan Stanley Terence Flynn $135 $143 +8 +19.8% $119.41
2025-07-14 Leerink Partners David Risinger $96 $114 +18 +1.7% $112.09
2025-06-18 Morgan Stanley Terence Flynn $130 $135 +5 +25.0% $108.00
2025-04-22 Cantor Fitzgerald Carter Gould Initiated $125 +18.5% $105.51
2025-03-11 Morgan Stanley Terence Flynn $84 $130 +46 +13.6% $114.43
2025-03-05 Johnson Rice Initiated $126 +9.1% $115.44
2025-03-04 Oppenheimer $90 $132 +42 +15.0% $114.74
2025-01-07 RBC Capital Brian Abrahams $72 $83 +11 -8.4% $90.63
2024-11-07 Piper Sandler Joseph Catanzaro $95 $105 +10 +16.6% $90.09
2024-10-21 BMO Capital Evan David Seigerman $85 $94 +9 +9.2% $86.11
2024-10-21 Leerink Partners Andrew Berens $91 $96 +5 +10.7% $86.72

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GILD receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-12 A- B+
2026-05-08 B+ A-
2026-02-03 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

77 Grade A+
Profitability
96
Balance Sheet
72
Earnings Quality
76
Growth
63
Value
49
Momentum
85
Safety
100
Cash Flow
76
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GILD scores highest in Safety (100/100) and lowest in Value (49/100). An overall grade of A+ places GILD among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.18
Safe Zone
Piotroski F-Score
9/9
Beneish M-Score
-2.55
Unlikely Manipulator
Ohlson O-Score
-8.87
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 82.0/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.17x
Accruals: -2.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GILD scores 4.18, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GILD scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GILD's score of -2.55 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GILD's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GILD receives an estimated rating of AA- (score: 82.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). GILD's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
18.11x
PEG
0.33x
P/S
5.61x
P/B
7.10x
P/FCF
17.09x
P/OCF
16.17x
EV/EBITDA
14.16x
EV/Revenue
6.35x
EV/EBIT
16.76x
EV/FCF
18.45x
Earnings Yield
5.27%
FCF Yield
5.85%
Shareholder Yield
3.23%
Graham Number
$54.61
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 18.1x earnings, GILD trades at a reasonable valuation. An earnings yield of 5.3% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $54.61 per share, 146% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.859
NI / EBT
×
Interest Burden
0.952
EBT / EBIT
×
EBIT Margin
0.379
EBIT / Rev
×
Asset Turnover
0.504
Rev / Assets
×
Equity Multiplier
2.813
Assets / Equity
=
ROE
43.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GILD's ROE of 43.9% is driven by Asset Turnover (0.504), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
18.40%
Fair P/E
45.31x
Intrinsic Value
$332.97
Price/Value
0.42x
Margin of Safety
58.14%
Premium
-58.14%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with GILD's realized 18.4% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $332.97, GILD appears undervalued with a 58% margin of safety. The adjusted fair P/E of 45.3x compares to the current market P/E of 18.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$134.36
Median 1Y
$149.84
5th Pctile
$99.27
95th Pctile
$226.10
Ann. Volatility
25.8%
Analyst Target
$166.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Daniel P. O’Day
Chairman and Chief Executive Officer
$1,795,192 $15,238,402 $28,437,198
Dietmar Berger, M.D.,
Ph.D. Chief Medical Officer
$969,231 $6,999,758 $13,922,878
Johanna Mercier Commercial
ercial and Corporate Affairs Officer
$1,182,269 $4,564,517 $9,300,643
Andrew D. Dickinson
Chief Financial Officer
$1,116,654 $4,321,741 $8,765,616
Deborah H. Telman
Former Executive Vice President, Corporate Affairs and General Counsel
$977,334 $3,071,792 $5,004,669

CEO Pay Ratio

85:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $28,437,198
Avg Employee Cost (SGA/emp): $335,824
Employees: 17,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
17,000
-3.4% YoY
Revenue / Employee
$1,731,941
Rev: $29,443,000,000
Profit / Employee
$500,588
NI: $8,510,000,000
SGA / Employee
$335,824
Avg labor cost proxy
R&D / Employee
$334,529
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 25.3% 36.3% 31.7% 23.0% 21.1% 17.0% 21.7% 26.4% 25.9% 27.8% 25.7% 2.2% 4.8% 0.6% 2.3% 28.3% 29.9% 38.5% 40.6% 43.9% 43.94%
ROA 7.9% 11.4% 9.1% 6.6% 6.1% 4.9% 7.0% 8.5% 8.4% 9.0% 9.0% 0.8% 1.7% 0.2% 0.8% 9.8% 10.4% 13.4% 14.4% 15.6% 15.62%
ROIC 17.7% 21.8% 18.0% 13.4% 12.6% 10.6% 14.4% 16.8% 15.7% 16.6% 15.3% 1.7% 4.2% 1.3% 3.3% 20.8% 20.5% 25.0% 26.2% 26.7% 26.70%
ROCE 13.6% 18.2% 16.5% 12.1% 11.6% 9.7% 13.0% 15.8% 15.9% 15.7% 15.3% 4.0% 4.9% 2.3% 3.5% 16.6% 17.5% 23.2% 22.9% 23.9% 23.86%
Gross Margin 77.6% 83.5% 63.7% 78.4% 77.0% 80.2% 81.1% 77.9% 78.1% 77.8% 70.6% 76.8% 77.8% 79.1% 79.1% 76.9% 78.8% 79.8% 79.5% 79.2% 79.24%
Operating Margin 36.1% 51.8% 13.0% 3.0% 32.4% 40.3% 30.7% 26.8% 25.2% 37.2% 22.7% -64.6% 38.0% 11.8% 32.4% 33.6% 34.9% 42.8% 37.7% 37.2% 37.16%
Net Margin 24.5% 34.9% 5.3% 0.3% 18.3% 25.4% 22.2% 15.9% 15.8% 30.9% 20.1% -62.4% 23.2% 16.6% 23.6% 19.7% 27.7% 39.3% 27.5% 29.0% 29.04%
EBITDA Margin 41.7% 56.7% 21.1% 9.3% 36.3% 45.2% 37.7% 34.2% 37.9% 45.9% 36.4% -53.0% 42.9% 25.0% 41.1% 39.1% 47.6% 59.0% 38.1% 33.8% 33.78%
FCF Margin 31.8% 34.5% 39.6% 36.2% 34.2% 33.2% 30.6% 31.0% 32.6% 28.7% 27.4% 28.8% 24.8% 33.3% 35.8% 34.3% 32.5% 31.5% 32.1% 34.4% 34.40%
OCF Margin 34.1% 36.7% 41.7% 38.6% 36.7% 35.8% 33.3% 33.2% 34.7% 30.7% 29.5% 30.9% 26.9% 35.4% 37.7% 36.1% 34.2% 33.2% 34.0% 36.3% 36.34%
ROE 3Y Avg snapshot only 24.57%
ROE 5Y Avg snapshot only 24.29%
ROA 3Y Avg snapshot only 8.83%
ROIC 3Y Avg snapshot only 14.04%
ROIC Economic snapshot only 20.96%
Cash ROA snapshot only 18.31%
Cash ROIC snapshot only 29.52%
CROIC snapshot only 27.94%
NOPAT Margin snapshot only 32.87%
Pretax Margin snapshot only 36.08%
R&D / Revenue snapshot only 19.48%
SGA / Revenue snapshot only 19.85%
SBC / Revenue snapshot only 1.53%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 14.18 10.16 12.67 14.48 16.61 20.82 21.26 17.02 16.21 14.85 16.79 178.16 77.90 804.85 235.67 23.17 21.75 17.05 18.07 18.96 18.107
P/S Ratio 2.75 2.73 2.89 2.38 2.50 2.56 3.58 3.51 3.25 3.18 3.51 3.14 2.95 3.58 3.93 4.81 4.76 4.75 5.22 5.88 5.610
P/B Ratio 4.02 4.13 3.74 3.10 3.26 3.29 4.60 4.47 4.19 4.11 4.16 3.78 3.59 4.44 5.85 7.15 7.10 7.15 6.80 7.73 7.097
P/FCF 8.64 7.91 7.30 6.57 7.30 7.71 11.70 11.33 9.96 11.11 12.81 10.92 11.90 10.75 10.98 14.04 14.65 15.09 16.27 17.09 17.086
P/OCF 8.05 7.44 6.93 6.16 6.80 7.15 10.76 10.59 9.35 10.38 11.88 10.17 10.98 10.12 10.45 13.33 13.91 14.30 15.35 16.17 16.173
EV/EBITDA 10.22 8.05 8.74 9.56 10.31 11.79 13.16 10.94 10.13 9.92 10.75 21.73 18.93 30.40 28.92 14.49 13.89 11.22 12.35 14.16 14.162
EV/Revenue 3.65 3.61 3.63 3.11 3.23 3.30 4.27 4.21 3.93 3.87 4.16 3.79 3.59 4.21 4.46 5.34 5.28 5.27 5.70 6.35 6.348
EV/EBIT 12.56 9.56 10.67 12.50 13.64 16.32 17.26 13.90 13.04 13.01 14.46 50.93 39.69 102.97 76.90 19.64 18.58 14.07 15.50 16.76 16.758
EV/FCF 11.47 10.44 9.16 8.60 9.44 9.95 13.96 13.58 12.07 13.51 15.20 13.16 14.47 12.63 12.45 15.58 16.27 16.75 17.75 18.45 18.453
Earnings Yield 7.1% 9.8% 7.9% 6.9% 6.0% 4.8% 4.7% 5.9% 6.2% 6.7% 6.0% 0.6% 1.3% 0.1% 0.4% 4.3% 4.6% 5.9% 5.5% 5.3% 5.27%
FCF Yield 11.6% 12.6% 13.7% 15.2% 13.7% 13.0% 8.5% 8.8% 10.0% 9.0% 7.8% 9.2% 8.4% 9.3% 9.1% 7.1% 6.8% 6.6% 6.1% 5.9% 5.85%
PEG Ratio snapshot only 0.328
EV/OCF snapshot only 17.468
EV/Gross Profit snapshot only 8.000
Acquirers Multiple snapshot only 16.594
Shareholder Yield snapshot only 3.23%
Graham Number snapshot only $54.61
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.40 1.40 1.27 1.27 1.27 1.27 1.29 1.29 1.29 1.29 1.43 1.43 1.43 1.43 1.60 1.60 1.60 1.60 1.68 1.68 1.683
Quick Ratio 1.26 1.26 1.13 1.13 1.13 1.13 1.15 1.15 1.15 1.15 1.27 1.27 1.27 1.27 1.45 1.45 1.45 1.45 1.31 1.31 1.314
Debt/Equity 1.73 1.73 1.27 1.27 1.27 1.27 1.19 1.19 1.19 1.19 1.09 1.09 1.09 1.09 1.38 1.38 1.38 1.38 1.09 1.09 1.087
Net Debt/Equity 1.32 1.32 0.96 0.96 0.96 0.96 0.89 0.89 0.89 0.89 0.78 0.78 0.78 0.78 0.78 0.78 0.78 0.78 0.62 0.62 0.618
Debt/Assets 0.46 0.46 0.39 0.39 0.39 0.39 0.40 0.40 0.40 0.40 0.40 0.40 0.40 0.40 0.45 0.45 0.45 0.45 0.42 0.42 0.417
Debt/EBITDA 3.30 2.55 2.36 2.98 3.10 3.51 2.85 2.42 2.37 2.36 2.38 5.22 4.74 6.38 6.02 2.52 2.43 1.95 1.81 1.85 1.845
Net Debt/EBITDA 2.52 1.95 1.78 2.26 2.34 2.65 2.13 1.81 1.77 1.76 1.69 3.70 3.36 4.52 3.41 1.43 1.38 1.11 1.03 1.05 1.049
Interest Coverage 7.61 10.06 9.27 6.97 6.73 5.80 7.22 8.84 9.03 8.88 8.27 2.11 2.58 1.18 1.71 7.94 8.19 10.70 10.56 11.21 11.208
Equity Multiplier 3.76 3.76 3.23 3.23 3.23 3.23 2.97 2.97 2.97 2.97 2.72 2.72 2.72 2.72 3.05 3.05 3.05 3.05 2.61 2.61 2.610
Cash Ratio snapshot only 0.898
Debt Service Coverage snapshot only 13.262
Cash to Debt snapshot only 0.431
FCF to Debt snapshot only 0.416
Defensive Interval snapshot only 463.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.41 0.42 0.40 0.40 0.40 0.40 0.42 0.41 0.42 0.42 0.43 0.44 0.44 0.45 0.47 0.47 0.48 0.48 0.50 0.50 0.504
Inventory Turnover 4.06 4.12 4.00 4.04 4.07 4.17 3.62 3.61 3.61 3.71 3.95 4.04 4.10 4.10 3.58 3.57 3.54 3.54 2.05 2.02 2.020
Receivables Turnover 6.29 6.49 5.82 5.85 5.86 5.78 5.89 5.83 5.91 5.91 5.75 5.82 5.89 6.00 6.33 6.33 6.36 6.41 6.31 6.37 6.372
Payables Turnover 6.80 6.90 8.52 8.60 8.67 8.89 7.03 7.00 7.00 7.21 8.93 9.14 9.28 9.29 9.04 9.02 8.96 8.95 14.97 14.74 14.739
DSO 58 56 63 62 62 63 62 63 62 62 64 63 62 61 58 58 57 57 58 57 57.3 days
DIO 90 88 91 90 90 87 101 101 101 98 93 90 89 89 102 102 103 103 178 181 180.7 days
DPO 54 53 43 42 42 41 52 52 52 51 41 40 39 39 40 40 41 41 24 25 24.8 days
Cash Conversion Cycle 94 92 111 110 110 110 111 112 111 109 115 113 112 111 119 120 120 119 211 213 213.2 days
Fixed Asset Turnover snapshot only 5.304
Operating Cycle snapshot only 238.0 days
Cash Velocity snapshot only 2.804
Capital Intensity snapshot only 1.985
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 20.1% 18.7% 10.6% 7.5% 3.3% -1.3% -0.1% -1.6% -0.5% 0.9% -0.6% 1.5% 1.5% 3.3% 6.0% 4.7% 3.8% 2.8% 2.4% 3.5% 3.48%
Net Income 21.1% 4.8% 49.6% 14.0% -19.9% -54.9% -26.2% 23.7% 32.6% 76.2% 23.3% -91.3% -80.8% -97.9% -91.5% 11.3% 5.0% 63.4% 16.7% 54.5% 54.50%
EPS 21.0% 4.8% 49.5% 14.0% -19.9% -54.9% -26.3% 23.8% 32.8% 76.8% 24.1% -91.2% -80.7% -97.9% -91.5% 11.2% 5.0% 63.4% 16.8% 55.1% 55.12%
FCF -0.4% 16.3% 43.7% 14.4% 11.1% -5.1% -22.8% -15.7% -5.2% -12.8% -11.1% -5.8% -22.7% 20.1% 38.9% 24.6% 35.9% -2.9% -8.2% 3.9% 3.91%
EBITDA 4.3% 2.0% 1.7% 97.3% -9.3% -38.2% -21.9% 16.4% 23.4% 40.7% 18.6% -54.0% -50.5% -63.3% -57.7% 1.2% 1.1% 2.5% 2.1% 25.9% 25.95%
Op. Income 11.2% 3.6% 1.4% 58.5% -28.4% -48.4% -26.1% 22.3% 20.9% 37.6% 3.8% -82.1% -69.8% -90.0% -78.1% 4.2% 2.1% 11.8% 5.6% 38.4% 38.37%
OCF Growth snapshot only 4.24%
Asset Growth snapshot only 0.05%
Equity Growth snapshot only 17.01%
Debt Growth snapshot only -7.93%
Shares Change snapshot only -0.40%
Dividend Growth snapshot only 2.41%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 4.7% 7.2% 7.3% 7.2% 7.2% 6.7% 6.7% 6.0% 7.3% 5.8% 3.2% 2.4% 1.4% 1.0% 1.7% 1.5% 1.6% 2.3% 2.6% 3.2% 3.21%
Revenue 5Y -3.8% -2.7% -2.1% -1.1% -0.7% -0.3% 0.9% 1.8% 3.4% 4.2% 4.1% 4.2% 4.5% 4.8% 5.1% 4.8% 5.4% 4.7% 3.6% 3.1% 3.07%
EPS 3Y 34.4% 69.0% 5.5% -8.0% -11.0% 7.5% -5.0% 4.3% 66.9% 2.6% 17.6% -41.0% -74.2% -57.4% 9.8% 15.3% 34.7% 23.2% 18.4% 18.40%
EPS 5Y -19.4% -12.2% -13.5% -17.9% -18.8% -21.4% 0.5% 11.0% 20.9% 30.9% 1.4% -39.0% -29.0% -45.7% -38.2% 3.9% 45.1% 1.3% 98.5% 98.49%
Net Income 3Y 32.7% 67.0% 4.5% -8.5% -11.4% 7.4% -5.2% 4.0% 66.7% 2.6% 17.2% -41.1% -74.3% -57.4% 9.7% 15.1% 34.5% 22.8% 18.2% 18.18%
Net Income 5Y -20.6% -13.3% -14.3% -18.6% -19.5% -22.1% -0.2% 10.0% 20.0% 29.9% 0.8% -39.3% -29.3% -45.8% -38.3% 3.8% 44.9% 1.3% 98.2% 98.24%
EBITDA 3Y -8.6% 2.3% 3.2% -5.5% -7.5% 4.3% 5.4% 13.1% 80.8% 37.4% 36.4% 1.8% -17.9% -31.7% -26.8% 5.8% 8.4% 21.6% 15.3% 8.6% 8.58%
EBITDA 5Y -15.3% -9.9% -10.0% -13.4% -13.8% -15.5% -11.1% -6.3% -3.1% -1.4% 0.4% -14.7% -13.5% -10.2% -10.1% 8.0% 43.6% 27.1% 26.9% 24.1% 24.07%
Gross Profit 3Y 4.5% 7.6% 6.2% 5.9% 5.4% 4.4% 6.8% 5.9% 7.7% 5.7% 0.8% 0.3% -0.5% -0.9% 2.8% 2.6% 2.9% 4.2% 2.4% 3.3% 3.29%
Gross Profit 5Y -5.4% -4.1% -4.5% -3.7% -3.0% -2.8% -0.1% 1.1% 3.1% 4.0% 3.6% 3.5% 3.5% 3.9% 4.8% 4.5% 5.4% 4.6% 2.9% 2.8% 2.75%
Op. Income 3Y -2.4% 7.6% 6.5% -4.5% -6.0% 11.4% 19.6% 25.7% 48.7% 23.2% -29.8% -36.1% -58.7% -44.9% 4.4% 4.7% 20.4% 14.6% 8.8% 8.78%
Op. Income 5Y -13.7% -9.6% -10.9% -15.5% -15.7% -17.7% -12.3% -6.7% -4.3% -2.4% -1.5% -28.2% -21.2% -28.3% -17.3% 13.1% 33.1% 22.1% 20.1% 20.06%
FCF 3Y 0.2% 6.3% 13.1% 13.8% 7.2% 3.9% 0.1% 0.6% 1.6% -1.3% -0.4% -3.2% -6.6% -0.2% -1.6% -0.4% -0.2% 0.6% 4.3% 6.8% 6.85%
FCF 5Y -13.3% -11.7% -7.8% -8.0% -7.3% -5.7% -5.9% -4.5% 1.1% -0.1% -0.1% 3.2% -2.0% 3.2% 4.4% 3.6% 1.9% 2.3% 4.7% 3.3% 3.30%
OCF 3Y -0.7% 4.7% 10.7% 11.3% 6.0% 2.9% -0.3% -0.1% 1.0% -1.6% -0.7% -3.2% -6.3% -0.2% -1.7% -0.8% -0.8% -0.1% 3.4% 6.4% 6.38%
OCF 5Y -12.8% -11.3% -7.7% -7.6% -6.8% -5.1% -5.3% -4.4% 0.5% -0.9% -1.0% 1.9% -2.5% 2.4% 3.4% 2.9% 1.4% 1.8% 4.2% 3.0% 2.95%
Assets 3Y -0.9% -0.9% 2.2% 2.2% 2.2% 2.2% 0.8% 0.8% 0.8% 0.8% -3.2% -3.2% -3.2% -3.2% -4.6% -4.6% -4.6% -4.6% -2.2% -2.2% -2.24%
Assets 5Y 5.8% 5.8% 3.6% 3.6% 3.6% 3.6% -2.1% -2.1% -2.1% -2.1% -0.5% -0.5% -0.5% -0.5% -0.9% -0.9% -0.9% -0.9% -2.9% -2.9% -2.91%
Equity 3Y -3.8% -3.8% -0.5% -0.5% -0.5% -0.5% -1.9% -1.9% -1.9% -1.9% 7.8% 7.8% 7.8% 7.8% -2.8% -2.8% -2.8% -2.8% 2.1% 2.1% 2.12%
Book Value 3Y -2.6% -2.7% 0.5% 0.1% -0.1% -0.3% -1.7% -1.7% -2.0% -1.8% 7.9% 8.3% 8.1% 8.1% -2.8% -2.8% -2.7% -2.7% 2.4% 2.3% 2.31%
Dividend 3Y 3.2% 2.9% 2.5% 1.9% 1.7% 1.3% 1.2% 1.1% 0.8% 0.9% 1.0% 1.3% 1.1% 1.1% 1.0% 1.0% 1.0% 1.0% 1.0% 1.0% 0.98%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.34 0.19 0.10 0.03 0.00 0.02 0.18 0.49 0.68 0.79 0.84 0.84 0.80 0.76 0.80 0.81 0.82 0.92 0.95 0.98 0.975
Earnings Stability 0.59 0.40 0.38 0.45 0.23 0.11 0.01 0.00 0.13 0.42 0.01 0.19 0.03 0.00 0.04 0.02 0.20 0.06 0.17 0.46 0.464
Margin Stability 0.96 0.96 0.95 0.95 0.96 0.95 0.96 0.97 0.97 0.97 0.97 0.97 0.97 0.97 0.98 0.98 0.98 0.97 0.98 0.98 0.977
Rev. Growth Consistency 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.50 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.20 0.50 0.50 0.50 0.50 0.50 0.90 0.91 0.87 0.50 0.91 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.00 0.00 0.00 0.78 0.24 0.70 0.79 0.72 0.45 0.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.57 0.572
ROE Trend 0.15 0.32 0.17 0.10 0.06 -0.07 0.07 0.15 0.02 -0.01 -0.01 -0.22 -0.18 -0.21 -0.21 0.17 0.17 0.28 0.24 0.24 0.243
Gross Margin Trend 0.01 0.01 -0.05 -0.04 -0.04 -0.05 0.01 0.01 0.02 0.01 -0.02 -0.02 -0.02 -0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.023
FCF Margin Trend -0.04 -0.01 0.06 0.01 -0.01 -0.02 -0.04 -0.04 -0.00 -0.05 -0.08 -0.05 -0.09 0.02 0.07 0.04 0.04 0.01 0.01 0.03 0.029
Sustainable Growth Rate 8.0% 18.8% 13.3% 4.5% 2.4% -1.8% 4.2% 8.7% 8.2% 9.9% 8.4% -15.2% -12.7% -17.1% -16.3% 9.6% 11.2% 19.6% 21.5% 24.7% 24.71%
Internal Growth Rate 2.6% 6.3% 4.0% 1.3% 0.7% 1.4% 2.9% 2.7% 3.3% 3.1% 3.5% 4.0% 7.3% 8.3% 9.6% 9.63%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.76 1.37 1.83 2.35 2.44 2.91 1.98 1.61 1.73 1.43 1.41 17.52 7.09 79.54 22.56 1.74 1.56 1.19 1.18 1.17 1.173
FCF/OCF 0.93 0.94 0.95 0.94 0.93 0.93 0.92 0.93 0.94 0.93 0.93 0.93 0.92 0.94 0.95 0.95 0.95 0.95 0.94 0.95 0.947
FCF/Net Income snapshot only 1.110
OCF/EBITDA snapshot only 0.811
CapEx/Revenue 2.3% 2.2% 2.1% 2.4% 2.5% 2.6% 2.7% 2.2% 2.1% 2.0% 2.2% 2.1% 2.1% 2.1% 1.8% 1.8% 1.7% 1.7% 1.9% 1.9% 1.94%
CapEx/Depreciation snapshot only 0.279
Accruals Ratio -0.06 -0.04 -0.08 -0.09 -0.09 -0.09 -0.07 -0.05 -0.06 -0.04 -0.04 -0.13 -0.10 -0.16 -0.17 -0.07 -0.06 -0.03 -0.03 -0.03 -0.027
Sloan Accruals snapshot only -0.020
Cash Flow Adequacy snapshot only 2.345
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 4.8% 4.8% 4.6% 5.6% 5.3% 5.3% 3.8% 3.9% 4.2% 4.3% 4.0% 4.4% 4.7% 3.8% 3.5% 2.8% 2.9% 2.9% 2.6% 2.3% 2.37%
Dividend/Share $2.80 $2.83 $2.86 $2.88 $2.90 $2.92 $2.93 $2.96 $2.99 $3.01 $3.03 $3.07 $3.08 $3.10 $3.11 $3.13 $3.16 $3.18 $3.19 $3.22 $3.19
Payout Ratio 68.4% 48.3% 57.9% 80.5% 88.4% 1.1% 80.8% 66.9% 68.5% 64.4% 67.2% 7.9% 3.7% 30.9% 8.2% 66.0% 62.7% 49.1% 47.0% 43.8% 43.76%
FCF Payout Ratio 41.7% 37.6% 33.4% 36.5% 38.9% 40.9% 44.5% 44.5% 42.1% 48.1% 51.3% 48.5% 55.9% 41.2% 38.0% 40.0% 42.3% 43.5% 42.3% 39.4% 39.43%
Total Payout Ratio 79.1% 55.0% 66.7% 93.5% 1.0% 1.3% 1.1% 92.7% 96.3% 92.3% 84.9% 10.0% 4.6% 38.4% 10.6% 90.8% 93.0% 74.3% 69.6% 61.2% 61.24%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.11 0.10 0.09 0.10 0.09 0.09 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06 0.05 0.05 0.05 0.047
Buyback Yield 0.8% 0.7% 0.7% 0.9% 0.9% 0.9% 1.4% 1.5% 1.7% 1.9% 1.1% 1.2% 1.2% 0.9% 1.0% 1.1% 1.4% 1.5% 1.2% 0.9% 0.92%
Net Buyback Yield 0.6% 0.4% 0.5% 0.6% 0.7% 0.7% 1.1% 1.2% 1.3% 1.4% 0.8% 0.8% 0.8% 0.7% 0.6% 0.7% 1.0% 1.1% 1.0% 0.7% 0.74%
Total Shareholder Return 5.4% 5.2% 5.1% 6.2% 6.0% 6.0% 4.9% 5.1% 5.6% 5.8% 4.8% 5.3% 5.5% 4.5% 4.1% 3.5% 3.9% 4.0% 3.6% 3.0% 3.05%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.77 0.79 0.75 0.77 0.75 0.73 0.79 0.77 0.75 0.81 0.83 0.45 0.68 0.72 0.70 0.87 0.88 0.82 0.87 0.86 0.859
Interest Burden (EBT/EBIT) 0.87 0.90 0.89 0.86 0.85 0.83 0.86 0.89 0.89 0.89 0.88 0.53 0.61 0.15 0.41 0.87 0.88 0.91 0.91 0.95 0.952
EBIT Margin 0.29 0.38 0.34 0.25 0.24 0.20 0.25 0.30 0.30 0.30 0.29 0.07 0.09 0.04 0.06 0.27 0.28 0.37 0.37 0.38 0.379
Asset Turnover 0.41 0.42 0.40 0.40 0.40 0.40 0.42 0.41 0.42 0.42 0.43 0.44 0.44 0.45 0.47 0.47 0.48 0.48 0.50 0.50 0.504
Equity Multiplier 3.19 3.19 3.47 3.47 3.47 3.47 3.10 3.10 3.10 3.10 2.84 2.84 2.84 2.84 2.87 2.87 2.87 2.87 2.81 2.81 2.813
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $4.10 $5.86 $4.93 $3.58 $3.28 $2.64 $3.63 $4.43 $4.36 $4.67 $4.51 $0.39 $0.84 $0.10 $0.38 $4.74 $5.03 $6.47 $6.79 $7.35 $7.35
Book Value/Share $14.45 $14.42 $16.69 $16.69 $16.72 $16.71 $16.80 $16.84 $16.88 $16.90 $18.18 $18.31 $18.25 $18.21 $15.35 $15.35 $15.40 $15.41 $18.05 $18.04 $18.87
Tangible Book/Share $-18.28 $-18.25 $-16.42 $-16.42 $-16.44 $-16.43 $-12.63 $-12.66 $-12.69 $-12.70 $-9.50 $-9.57 $-9.54 $-9.52 $-7.09 $-7.09 $-7.12 $-7.12 $-2.13 $-2.13 $-2.13
Revenue/Share $21.14 $21.78 $21.64 $21.77 $21.84 $21.52 $21.58 $21.45 $21.77 $21.79 $21.59 $22.01 $22.22 $22.57 $22.84 $22.82 $23.00 $23.19 $23.50 $23.71 $23.94
FCF/Share $6.72 $7.52 $8.56 $7.89 $7.47 $7.14 $6.60 $6.65 $7.10 $6.25 $5.91 $6.34 $5.51 $7.52 $8.19 $7.82 $7.47 $7.31 $7.55 $8.16 $8.24
OCF/Share $7.22 $8.00 $9.02 $8.41 $8.02 $7.70 $7.18 $7.12 $7.56 $6.69 $6.37 $6.80 $5.97 $7.99 $8.60 $8.23 $7.86 $7.71 $8.00 $8.62 $8.70
Cash/Share $5.88 $5.87 $5.17 $5.17 $5.17 $5.17 $5.05 $5.06 $5.08 $5.08 $5.78 $5.83 $5.81 $5.79 $9.19 $9.19 $9.22 $9.22 $8.46 $8.46 $7.90
EBITDA/Share $7.55 $9.75 $8.98 $7.09 $6.84 $6.03 $7.00 $8.26 $8.46 $8.50 $8.36 $3.84 $4.21 $3.13 $3.52 $8.41 $8.74 $10.90 $10.84 $10.63 $10.63
Debt/Share $24.92 $24.88 $21.15 $21.15 $21.19 $21.17 $19.96 $20.01 $20.06 $20.07 $19.89 $20.04 $19.97 $19.93 $21.22 $21.22 $21.28 $21.30 $19.63 $19.61 $19.61
Net Debt/Share $19.04 $19.01 $15.99 $15.99 $16.01 $16.00 $14.91 $14.94 $14.98 $14.99 $14.11 $14.21 $14.17 $14.13 $12.03 $12.03 $12.07 $12.08 $11.16 $11.15 $11.15
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 4.178
Altman Z-Prime snapshot only 7.220
Piotroski F-Score 6 7 5 6 5 4 6 7 8 7 7 6 6 7 6 7 7 8 9 9 9
Beneish M-Score -2.14 -2.08 -2.76 -2.96 -2.95 -2.98 -2.94 -2.75 -2.82 -2.64 -2.59 -3.12 -2.95 -3.28 -3.48 -2.92 -2.87 -2.70 -2.49 -2.55 -2.551
Ohlson O-Score snapshot only -8.870
Net-Net WC snapshot only $-13.17
EVA snapshot only $6112372390.01
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA-
Credit Score 53.70 61.41 58.19 54.93 54.28 54.99 63.13 65.74 64.48 65.28 64.25 46.78 46.87 46.66 48.60 70.18 69.79 78.44 80.08 81.95 81.953
Credit Grade snapshot only 4
Credit Trend snapshot only 11.774
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 61
Sector Credit Rank snapshot only 82

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms